Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: A morphologic and phenotypic study on 47 skin biopsies

American Journal of Dermatopathology

Volumn 32, Issue 8, 2010, Pages 755-763

  Ram Wolff, Caroline ^a   Martin Garcia, Nadine ^a,b   Bensussan, Armand ^c   Bagot, Martine ^c   Ortonne, Nicolas ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

catenin; CD30; erythroderma; histopathology; JunB; S zary syndrome

Indexed keywords

BETA CATENIN; CD3 ANTIGEN; CD30 ANTIGEN; CD8 ANTIGEN; EOSIN; HEMATOXYLIN; TRANSCRIPTION FACTOR JUNB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CUTANEOUS T CELL LYMPHOMA; DERMIS; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; ECZEMA; ERYTHRODERMA; EXOCYTOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY ERYTHRODERMA; LYMPHOCYTE; LYMPHOMA; LYMPHOMATOUS ERYTHRODERMA; MALE; MORPHOLOGY; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN EDEMA; SKIN INFILTRATE; SKIN INFLAMMATION; STAINING; TELANGIECTASIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD8; BETA CATENIN; BIOPSY; DERMATITIS; DERMATITIS, EXFOLIATIVE; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; ECZEMA; FEMALE; FRANCE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTES; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-JUN; PSORIASIS; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS;

EID: 78650416338     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181cfbfbf     Document Type: Article

References (38)

1. Akhyani M, Ghodsi ZS, Toosi S, et al. Erythroderma: a clinical study of 97 cases. BMC Dermatol. 2005;5;1-5.
2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105;3768-3785.
3. Curco N, Servitje O, Llucia M, et al. Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene. Br J Dermatol. 1997;137;673-679.
4. Gorochov G, Bachelez H, Cayuela JM, et al. Expression of V beta gene segments by Sezary cells. J Invest Dermatol. 1995;105;56-61.
5. Guitart J, Kaul K. A new polymerase chain reaction-based method for the detection of T-cell clonality in patients with possible cutaneous T-cell lymphoma. Arch Dermatol. 1999;135;158-162.
6. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol. 1994;103;34-41.
7. Witzens M, Möhler T, Willhauck M, et al. Detection of clonally rearranged T-cell-receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis. Ann Hematol. 1997;74;123-130.
8. Delfau-Larue MH, Laroche L, Wechsler J, et al. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood. 2000;96;2987-2992.
9. Jones D, Dang NH, Duvic M, et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol. 2001;115;885-892.
10. Scala E, Narducci MG, Amerio P, et al. T cell receptor-Vbeta analysis identifies a dominant CD60+ CD26-CD49d-T cell clone in the peripheral blood of Sézary syndrome patients. J Invest Dermatol. 2002;119; 193-196.
11. Bernengo MG, Novelli M, Quaglino P, et al. The relevance of the CD4+ CD26-subset in the identification of circulating Sézary cells. Br J Dermatol. 2001;144;125-135.
12. Rappl G, Muche JM, Abken H, et al. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol. 2001;44;456-461.
13. van Doorn R, Dijkman R, Vermeer MH, et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis. Cancer Res. 2004;64; 5578-5586.
14. Su MW, Dorocicz I, Dragowska WH, et al. Aberrant expression of T-plastin in Sezary cells. Cancer Res. 2003;63;7122-7127.
15. Bagot M, Moretta A, Sivori S, et al. CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood. 2001;97;1388-1391.
16. Poszepczynska-Guigné E, Schiavon V, D'Incan M, et al. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol. 2004; 122;820-823.
17. Ortonne N, Le Gouvello S, Mansour H, et al. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome. J Invest Dermatol. 2008;128; 465-472.
18. Provost E, Rimm DL. Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol. 1999;11; 567-572.
19. Miller JR, Hocking AM, Brown JD, et al. Mechanisms and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca+ pathways. Oncogene. 1999;18;7860-7872.
20. Barker N, Clevers H. Catenins, Wnt signaling and cancer. Bioassays. 2000;22;961-965.
21. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev. 1999;9;15-21.
22. Bellei B, Pacchiarotti A, Perez M, et al. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas. Mod Pathol. 2004;17;1275-1281.
23. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4;E131-E136.
24. Rassidakis GZ, Thomaides A, Atwell C, et al. JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis. Mod Pathol. 2005;18;1365-1370.
25. Mao X, Orchard G, Lillington DM, et al. Amplification and over-expression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood. 2003;101;1513-1519.
26. Ortonne N, Huet D, Gaudez C, et al. Significance of circulating T-cell clones in Sezary syndrome. Blood. 2006;107;4030-4038.
27. Massone C, Kodama K, Kerl H, et al. Histopathologic features of early (patch) lesions of Mycosis Fungoides. Am J Surg Pathol. 2005;29; 550-560.
28. Trotter MJ, Whittaker SJ, Orchard GE, et al. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cutan Pathol. 1997;24;286-291.
29. Zip C, Murray S, Walsh NM. The specificity of histopathology in erythroderma. J Cutan Pathol. 1993;20;393-398.
30. Kamarashev J, Burg G, Kempf W, et al. Comparative analysis of histological and immunohistological features in Mycosis Fungoides and Sézary syndrome. J Cutan Pathol. 1998;25;407-412.
31. Kohler S, Kim YH, Smoller BR. Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sézary syndrome: a critical reappraisal. J Cutan Pathol. 1997;24;292-297.
32. Walsh NMG, Prokopetz R, Tron VA, et al. Histopathology in erythroderma: review of a series of cases by multiple observers. J Cutan Pathol. 1994;21;419-423.
33. Sentis HJ, Willemze R, Scheffer E. Histopathologic studies in Sezary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol. 1986;15;1217-1226.
34. Werner B, Massone C, Kerl H, et al. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. J Cutan Pathol. 2008;35; 1100-1107.
35. Gattinoni L, Zhong XS, Palmer DC, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med. 2009;15:808-814.
36. Watanabe M, Sasaki M, Itoh K, et al. JunB induced by constitutive CD30-extracellular signal-regulated kinase / mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and Reed-Sternberg cells of Hodgkin lymphoma. Cancer Res. 2005;65; 7628-7634.
37. Karenko L, Hahtola S, Paivinen S, et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005;65:8101-8110.
38. Marty M, Prochazkova M, Laharanne E, et al. Primary cutaneous T-cell lymphomas do not shown specific NAV3 gene deletion or translocation. J Invest Dermatol. 2008;128:2458-2466.